Profile data is unavailable for this security.
About the company
3-D Matrix, Ltd. is a company engaged in the research, development, manufacture and sale of medical products. The Company has Medical Product segment. The segment consists of two divisions. The medical product development and sales division is engaged in the research and development of medical equipment and drugs for surgery area, regeneration medicine area and drug delivery system (DDS) area based on the self-organizing peptide technology, including hemostatic, vascular embolization and alveolar bone reconstruction materials, among others. The research reagents sales division is engaged in the sale of medical products based on the self-organizing peptide technology for research and test use in universities and research institutes.
- Revenue in JPY (TTM)5.25bn
- Net income in JPY-1.05bn
- Incorporated2004
- Employees106.00
- Location3-D Matrix Ltd7FKojimachi HF Bldg., 3-2-4, Koji-machiCHIYODA-KU 102-0083JapanJPN
- Phone+81 335113440
- Fax+81 335113402
- Websitehttps://www.3d-matrix.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veritas In Silico Inc | 246.24m | -148.31m | 5.87bn | 15.00 | -- | 2.55 | -- | 23.84 | -23.92 | -23.92 | 38.93 | 354.61 | 0.1227 | -- | -- | 16,415,930.00 | -7.39 | -- | -7.65 | -- | -- | -- | -60.23 | -- | 67.03 | -- | -- | -- | 101.54 | -- | 123.38 | -- | -- | -- |
| Carna Biosciences, Inc. | 1.40bn | -1.51bn | 5.94bn | 67.00 | -- | 2.11 | -- | 4.24 | -85.98 | -85.98 | 80.34 | 147.09 | 0.391 | 1.19 | 13.59 | 20,922,580.00 | -42.15 | -14.45 | -45.45 | -16.95 | 87.53 | 90.59 | -107.80 | -35.42 | 11.11 | -- | 0.0215 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
| Noile-Immune Biotech Inc | 8.12m | -1.07bn | 7.27bn | 28.00 | -- | 1.48 | -- | 896.12 | -24.64 | -24.64 | 0.1875 | 113.23 | 0.0015 | 0.0229 | 0.0283 | 289,928.60 | -19.15 | -- | -19.61 | -- | 95.58 | -- | -13,139.53 | -- | 79.60 | -- | -- | -- | -49.37 | -- | -192.28 | -- | -- | -- |
| OncoTherapy Science, Inc. | 478.75m | -1.12bn | 8.15bn | 54.00 | -- | 8.15 | -- | 17.02 | -4.86 | -4.86 | 2.04 | 3.68 | 0.3526 | 4.34 | 9.77 | 8,865,722.00 | -82.71 | -55.67 | -106.53 | -63.82 | -32.12 | -1.49 | -234.61 | -247.47 | 3.11 | -- | 0.0731 | -- | -46.24 | 16.81 | -15.15 | -- | -48.33 | -- |
| TMS Co Ltd | 0.00 | -1.10bn | 8.27bn | 14.00 | -- | 2.77 | -- | -- | -28.37 | -28.37 | 0.00 | 74.10 | 0.00 | -- | -- | 0.00 | -33.57 | -- | -34.42 | -- | -- | -- | -- | -- | 31.13 | -- | 0.00 | -- | -- | -- | -11.51 | -- | -- | -- |
| Linical Co Ltd | 11.67bn | -121.16m | 8.54bn | 662.00 | -- | 1.06 | 20.77 | 0.7314 | -5.36 | -5.36 | 516.67 | 326.90 | 0.6575 | -- | 3.74 | 17,628,030.00 | -0.6826 | 4.01 | -1.18 | 6.33 | 26.63 | 30.99 | -1.04 | 5.48 | -- | 2.65 | 0.2588 | 50.81 | -1.67 | 1.70 | -66.32 | -9.86 | -10.18 | 4.56 |
| Modalis Therapeutics Corp | 0.00 | -1.87bn | 9.23bn | 37.00 | -- | 3.00 | -- | -- | -52.79 | -52.79 | 0.00 | 44.35 | 0.00 | -- | -- | 0.00 | -74.95 | -29.19 | -78.46 | -30.02 | -- | -- | -- | -597.35 | 43.87 | -87.46 | 0.0771 | -- | -100.00 | -- | 11.50 | -- | 135.50 | -- |
| Chiome Bioscience Inc | 581.07m | -1.22bn | 9.37bn | 51.00 | -- | 7.56 | -- | 16.12 | -22.07 | -22.07 | 10.53 | 19.85 | 0.3371 | 5.16 | 8.01 | 11,393,550.00 | -70.61 | -50.50 | -95.97 | -57.38 | 53.55 | 57.53 | -209.45 | -224.74 | 3.57 | -894.37 | 0.1995 | -- | 8.19 | 26.24 | 1.84 | -- | -- | -- |
| Medinet Co Ltd | 768.50m | -1.28bn | 10.58bn | 98.00 | -- | 2.04 | -- | 13.77 | -5.04 | -5.04 | 3.05 | 19.62 | 0.1356 | 11.15 | 3.46 | -- | -22.53 | -21.15 | -23.83 | -22.39 | 14.66 | 22.97 | -166.17 | -160.19 | 18.45 | -- | 0.0002 | -- | 16.17 | -6.21 | 11.19 | -- | -11.16 | -- |
| 3-D Matrix Ltd | 5.25bn | -1.05bn | 11.06bn | 106.00 | -- | 9.52 | -- | 2.11 | -12.89 | -12.89 | 66.88 | 11.66 | 0.8559 | 0.551 | 5.40 | 49,502,420.00 | -17.15 | -42.10 | -21.31 | -55.60 | 68.38 | 53.95 | -20.04 | -96.03 | 2.51 | -- | 0.7979 | -- | 98.30 | 69.41 | 89.55 | -- | -30.34 | -- |
| Tsubota Laboratory Inc | 1.11bn | -303.08m | 11.13bn | 7.00 | -- | 7.88 | -- | 10.02 | -12.09 | -12.09 | 43.15 | 55.21 | 0.4899 | 1.60 | 5.16 | 158,704,300.00 | -13.37 | -- | -18.33 | -- | 52.59 | -- | -27.28 | -- | 2.57 | -24.64 | 0.0678 | -- | -29.45 | -- | -811.14 | -- | -- | -- |
| PRISM BioLab Co Ltd | -100.00bn | -100.00bn | 11.83bn | 22.00 | -- | 5.60 | -- | -- | -- | -- | -- | 58.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -79.63 | -- | -822.18 | -- | -- | -- |
| Nano Mrna Co Ltd | 52.10m | -821.00m | 11.87bn | 18.00 | -- | 3.88 | -- | 227.74 | -11.66 | -11.66 | 0.74 | 43.30 | 0.0102 | 7.01 | 1.56 | 2,894,445.00 | -16.13 | -24.16 | -17.89 | -25.17 | 80.72 | 84.69 | -1,575.81 | -600.70 | 8.17 | -- | 0.2662 | -- | -32.98 | -22.88 | 40.50 | -- | -- | -- |
| AnGes Inc | 521.96m | -9.80bn | 14.46bn | 145.00 | -- | 0.6128 | -- | 27.71 | -45.15 | -45.15 | 2.42 | 86.48 | 0.0174 | 0.2324 | 11.18 | 3,599,697.00 | -32.66 | -28.50 | -36.48 | -33.14 | 37.08 | 39.42 | -1,876.83 | -6,726.82 | 2.36 | -12.15 | 0.0672 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
| Chordia Therapeutics Inc | 0.00 | -1.83bn | 15.14bn | 21.00 | -- | 3.63 | -- | -- | -31.95 | -31.95 | 0.00 | 61.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -500.25 | -- | -- | -- | -- | -918.09 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to 3-D Matrix Ltd's reporting currency: Japanese Yen JPY
0.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 07 Nov 2024 | 442.10k | 0.45% |
| Heights Capital Management, Inc.as of 17 Oct 2024 | 34.00 | 0.00% |
Data from 30 Sep 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
